AG
DPLO

Aperio Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Aperio Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-37,901
Closed -$186K – 2363
2019
Q3 		$186K Buy
37,901
+9,597
+34% +$53.7K ﹤0.01% 2180
2019
Q2 		$172K Buy
28,304
+15,834
+127% +$84.2K ﹤0.01% 2227
2019
Q1 		$72K Sell
12,470
-1,925
-13% -$19.9K ﹤0.01% 2261
2018
Q4 		$194K Sell
14,395
-7,205
-33% -$121K ﹤0.01% 2136
2018
Q3 		$419K Buy
21,600
+15
+0.1% +$319 ﹤0.01% 1861
2018
Q2 		$552K Buy
21,585
+555
+3% +$12.9K ﹤0.01% 1702
2018
Q1 		$424K Buy
21,030
+336
+2% +$7.84K ﹤0.01% 1776
2017
Q4 		$415K Buy
20,694
+687
+3% +$13.5K ﹤0.01% 1788
2017
Q3 		$414K Buy
20,007
+214
+1% +$3.62K ﹤0.01% 1751
2017
Q2 		$293K Buy
19,793
+5,526
+39% +$92.1K ﹤0.01% 1912
2017
Q1 		$228K Buy
+14,267
New +$206K ﹤0.01% 1974

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aperio Group's DPLO Position: Q4 2019 in Review

Aperio Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 37,901 shares — an estimated $186K sold.

Aperio Group first reported a position in DPLO in Q1 2017 and held it in 11 quarters. The position peaked at $552K in Q2 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Aperio Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Aperio Group sold 37,901 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $186K.
  • Aperio Group first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 11 quarters.
  • Aperio Group's DIPLOMAT PHARMACY, INC. position peaked at $552K in Q2 2018.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.